United States · 
What does Cobro Ventures invest in?
Cobro Ventures invests most often at Series B (100% of the rounds on record), in sectors such as Metabolomics, Transcriptomics and Genomics.
Cobro Ventures highlights
- 01
1 rounds on record
- 02
Mostly Series B: 100% of its rounds
What they do
Filed 1 private fund offering with the SEC, the most recent in 2021-06From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- $100K – $5.0M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- MetabolomicsTranscriptomicsGenomics
- Based in
- McLean, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2019
1 round
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
AJAlain J. CohenManaging Member of Cobro Opportunity Fund GP, LLCiForm ADV
DKDennis KlinmanMember of Cobro II GP, LLCiForm ADV
FSFred ShaneMember of Cobro II GP, LLCiForm ADV
MAMarc A. CohenMANAGING MEMBERiFiling they signed
TKTodd KaloudisManaging Member of Cobro Opportunity Fund GP, LLCiForm ADV
We also hold 8 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$76Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Cobro Ventures Management, LLC
- SEC number
- CRD 309434
What they claim to have backed
From their own portfolio page (on their website)
1 of 4 we have independently watched raise
AiproteinsAxisimagingnewsBublupScitechdaily
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.